IXICO (LON:IXI) Announces Earnings Results

IXICO (LON:IXIGet Free Report) issued its quarterly earnings results on Tuesday. The company reported GBX (1.21) earnings per share for the quarter, Digital Look Earnings reports. IXICO had a negative return on equity of 13.74% and a negative net margin of 25.27%.The business had revenue of GBX 395 million for the quarter.

IXICO Stock Performance

Shares of IXICO stock opened at GBX 8.30 on Thursday. The company has a current ratio of 3.03, a quick ratio of 4.90 and a debt-to-equity ratio of 1.53. The business has a 50-day moving average price of GBX 7.37 and a two-hundred day moving average price of GBX 9.44. IXICO has a 1-year low of GBX 6.26 and a 1-year high of GBX 15. The company has a market cap of £18.10 million, a P/E ratio of -4.49, a PEG ratio of -0.38 and a beta of 0.07.

About IXICO

(Get Free Report)

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.

Featured Stories

Earnings History for IXICO (LON:IXI)

Receive News & Ratings for IXICO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IXICO and related companies with MarketBeat.com's FREE daily email newsletter.